1 Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction [J]. Science, 1982; 217(4558): 408-14 2 Gilman S. Alzheimer' s disease[J]. Perspect BiolMed, 1997; 40(2): 230-45 3 Kasa P, Rakonczay Z, Gulya K.The cholinergic system in Alzheimer' s disease[J]. Neurobiol, 1997;52(6): 511-35 4 Paul SM, Purdy RH.Neuroactive steroids[J]. FASEB J, 1992; 6(6): 2311-22 5 Robel P, Baulieu EE. Neurosteroids:biosynthesis and function [J]. Crit Rev Neurobiol, 1995;9(4): 383-94 6 Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor[J]. Mol Pharmacol, 1991; 40(3): 333-6 7 Darnaudery M, Koehl M, Piazza PV, et al. Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition[J]. Brain Res, 2000; 852(1): 173-9 8 Budziszewska B, Siwanowicz J, LeSkiewiczM, et al. Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice[J]. Eur Neuropsy chopharmacol, 1998;8(1): 7-12 9 Asbury ET, FrittsME, Horton JE, Isaac WL.Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat[J]. Behav Brain Res, 1998;97(1-2): 99-106 10 Chesler EJ, Juraska JM. Acute administration of estrogen and progesterone impairs the acquisition of the spatial morris water maze in ovariectomized Rats[J]. Horm Behav, 2000;38(4): 234-42 11 Vongher JM, Frye CA.Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration[J]. Pharmacol Biochem Behav, 1999;64(4): 777-85 12 Davies P, Verth AH. Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer' s type dementia brains[J]. Brain Res, 1978;138(2): 385-92 13 Mash DC, Flynn DD, Potter LT.Loss ofM2 muscarine receptors in the cerebral cortex in Alzheimer' s disease and experimental cholinergic denervation[J]. Science, 1985;228(4703): 1115-7 14 Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia[J]. J Neurochem, 1986; 46(1): 288-93 |